Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TacroBell SR Conversion in Liver Transplant Maintenance
NCT04069065Phase 4Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jul 2019
- Primary completion
- Feb 2021
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in Liver transplant rejection, sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT04069065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069065.